Lipidomic Profiling of a Preclinical Model of Streptozotocin-Induced Diabetic Cardiomyopathy Reveals Potential Plasma Biomarkers

Scritto il 14/05/2025
da Bianca C Bernardo

No abstract

Heart Lung Circ. 2025 May 13:S1443-9506(25)00183-0. doi: 10.1016/j.hlc.2024.11.036. Online ahead of print.

NO ABSTRACT

PMID:40368670 | DOI:10.1016/j.hlc.2024.11.036